2-[25-[4-[2-(13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24,26,28-tetradecaen-13-yl)benzo[h]quinazolin-4-yl]dibenzofuran-2-yl]-13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24(29),25,27-tetradecaen-13-yl]-4-dibenzofuran-1-yl-[1]benzofuro[2,3-d]pyrimidine
C102H54N6O3 — CID 166821221
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[25-[4-[2-(13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24,26,28-tetradecaen-13-yl)benzo[h]quinazolin-4-yl]dibenzofuran-2-yl]-13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24(29),25,27-tetradecaen-13-yl]-4-dibenzofuran-1-yl-[1]benzofuro[2,3-d]pyrimidine
2-[25-[4-[2-(13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24,26,28-tetradecaen-13-yl)benzo[h]quinazolin-4-yl]dibenzofuran-2-yl]-13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24(29),25,27-tetradecaen-13-yl]-4-dibenzofuran-1-yl-[1]benzofuro[2,3-d]pyrimidine (PubChem CID 166821221) has the molecular formula C102H54N6O3 and a molecular weight of 1411.59 g/mol. Its IUPAC name is 2-[25-[4-[2-(13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24,26,28-tetradecaen-13-yl)benzo[h]quinazolin-4-yl]dibenzofuran-2-yl]-13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24(29),25,27-tetradecaen-13-yl]-4-dibenzofuran-1-yl-[1]benzofuro[2,3-d]pyrimidine.
Molecular Properties
| Compound Name | 2-[25-[4-[2-(13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24,26,28-tetradecaen-13-yl)benzo[h]quinazolin-4-yl]dibenzofuran-2-yl]-13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24(29),25,27-tetradecaen-13-yl]-4-dibenzofuran-1-yl-[1]benzofuro[2,3-d]pyrimidine |
|---|---|
| PubChem CID | 166821221 |
| Molecular Formula | C102H54N6O3 |
| Molecular Weight | 1411.59 g/mol |
| Exact Mass | 1410.43 |
| IUPAC Name | 2-[25-[4-[2-(13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24,26,28-tetradecaen-13-yl)benzo[h]quinazolin-4-yl]dibenzofuran-2-yl]-13-azaheptacyclo[15.12.0.02,14.03,12.05,10.018,23.024,29]nonacosa-1(17),2(14),3,5,7,9,11,15,18,20,22,24(29),25,27-tetradecaen-13-yl]-4-dibenzofuran-1-yl-[1]benzofuro[2,3-d]pyrimidine |
| SMILES | c1ccc2cc3c(cc2c1)c1c2c4ccccc4c4ccccc4c2ccc1n3-c1nc(-c2cc(-c3cccc4c3c3ccccc3c3ccc5c(c6cc7ccccc7cc6n5-c5nc(-c6cccc7oc8ccccc8c67)c6c(n5)oc5ccccc56)c34)cc3c2oc2ccccc23)c2ccc3ccccc3c2n1 |
| InChI | InChI=1S/C102H54N6O3/c1-3-24-58-53-83-78(49-56(58)22-1)93-81(47-45-70-65-29-8-7-27-63(65)64-28-9-12-33-69(64)91(70)93)107(83)101-103-96-62-26-6-5-21-55(62)43-44-76(96)97(104-101)80-52-60(51-77-67-31-13-16-39-85(67)110-99(77)80)61-36-19-37-74-89(61)68-32-11-10-30-66(68)71-46-48-82-94(92(71)74)79-50-57-23-2-4-25-59(57)54-84(79)108(82)102-105-98(95-73-35-15-18-41-87(73)111-100(95)106-102)75-38-20-42-88-90(75)72-34-14-17-40-86(72)109-88/h1-54H |
| InChIKey | KBKCRYMCWRUFLT-UHFFFAOYSA-N |
| XLogP | 27.69 |
| TPSA | 100.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 111 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1411.59 |
| LogP ≤ 5 | 27.69 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166821221 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.